Evidence map›Paper›PMID 24515516›Full record

SynthesisPediatrics2014

Dexamethasone for acute asthma exacerbations in children: a meta-analysis.

Grant E Keeney, Matthew P Gray, Andrea K Morrison, Michael N Levas, Elizabeth A Kessler, Garick D Hill, Marc H Gorelick, Jeffrey L Jackson

4 registry-linked trialsAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02192827 phase3completednot on this mapstarted 2015, after this paper: background citation

Single Dose Dexamethasone is as Effective as Two Doses in Mild to Moderate Pediatric Asthma Exacerbations in the Emergency Department

TypeinterventionalSponsorUniversity at BuffaloRan2015 to 2018Enrolled318ConditionsAsthmaArmsDexamethasone Sodium Phosphate Injection
NCT02780479 phase4terminatednot on this mapstarted 2017, after this paper: background citation

Oral Dexamethasone Versus Oral Prednisone in Children Hospitalized With Asthma: A Randomized Control Study

TypeinterventionalSponsorUniversity of FloridaRan2017 to 2017Enrolled6ConditionsAsthma, Status Asthmaticus, WheezesArmsDexamethasone, Prednisone
NCT03900624 phase4completednot on this mapstarted 2019, after this paper: background citation

Ideal Steroids for Asthma Treatment in the PICU (iSTAT PICU): A Prospective, Comparative, Single-arm Study Assessing Dexamethasone Versus Methylprednisolone in Severe Status Asthmaticus Admitted to the Pediatric Intensive Care Unit

TypeinterventionalSponsorJohns Hopkins All Children's HospitalRan2019 to 2022Enrolled92ConditionsAsthma ChildhoodArmsDexamethasone
NCT07228052 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department: A Randomized Control Trial

TypeinterventionalSponsorMontefiore Medical CenterRan2026 to 2026Enrolled182ConditionsAsthmaArmsDexamethasone 16mg IM, Prednisone 60mg PO
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Different oral corticosteroid regimens for acute asthma.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Management of asthma exacerbations in pediatric emergency departments across the United States.The Journal of asthma : official journal of the Association for the Care of Asthma · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Trends and Variation in Pediatric Anaphylaxis Care From 2016 to 2022.The journal of allergy and clinical immunology. In practice · 2023
    Article
  17. Article
  18. Evaluation of Dexamethasone Dosing Strategies in Pediatric Asthma Exacerbations.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Grant E KeeneyDepartments of Pediatrics, and.
Matthew P Gray
Andrea K Morrison
Michael N Levas
Elizabeth A Kessler
Garick D Hill
Marc H Gorelick
Jeffrey L Jackson
Pediatrics and Genetics · USMedical College of Wisconsin · US

Funding

Clincal and Translational Science AwardUL1TR000055 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2012 to 2015
$11.3M
NCATS NIH HHS 8UL1TR000055NCATS NIH HHS UL1 TR000055
6 · The paper itself

Abstract

BACKGROUND AND

objectiveDexamethasone has been proposed as an equivalent therapy to prednisone/prednisolone for acute asthma exacerbations in pediatric patients. Although multiple small trials exist, clear consensus data are lacking. This systematic review and meta-analysis aimed to determine whether intramuscular or oral dexamethasone is equivalent or superior to a 5-day course of oral prednisone or prednisolone. The primary outcome of interest was return visits or hospital readmissions.

methodsA search of PubMed (Medline) through October 19, 2013, by using the keywords dexamethasone or decadron and asthma or status asthmaticus identified potential studies. Six randomized controlled trials in the emergency department of children ≤18 years of age comparing dexamethasone with prednisone/prednisolone for the treatment of acute asthma exacerbations were included. Data were abstracted by 4 authors and verified by a second author. Two reviewers evaluated study quality independently and interrater agreement was assessed.

resultsThere was no difference in relative risk (RR) of relapse between the 2 groups at any time point (5 days RR 0.90, 95% confidence interval [CI] 0.46-1.78, Q = 1.86, df = 3, I2 = 0.0%, 10-14 days RR 1.14, 95% CI 0.77-1.67, Q = 0.84, df = 2, I2 = 0.0%, or 30 days RR 1.20, 95% CI 0.03-56.93). Patients who received dexamethasone were less likely to experience vomiting in either the emergency department (RR 0.29, 95% CI 0.12-0.69, Q = 3.78, df = 3, I2 = 20.7%) or at home (RR 0.32, 95% CI 0.14-0.74, Q = 2.09, df = 2, I2 = 4.2%).

conclusionsPractitioners should consider single or 2-dose regimens of dexamethasone as a viable alternative to a 5-day course of prednisone/prednisolone.

Indexed as

Acute DiseaseAnti-Inflammatory AgentsAsthmaChildClinical Trials as TopicDexamethasoneHumansAnti-Inflammatory AgentsDexamethasoneasthmadexamethasoneprednisoloneprednisonestatus asthmaticus

Identifiers

PMID24515516
PMCPMC3934336
OpenAlexW2097488763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.